You are Here: Immigration

Immigration Law: A Brief Overview

Coming Soon...


Free Consultation  Call Now

Get Interactive
Live Chat
Chat with a knowledgeable paralegal about your case
 
 
Free Consultation
Receive an immediate response to your request.
Choose practice area of your problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy
CAPTCHA image
Enter the code shown above in the box below

Recent Articles & Publications

January 28, 2013
The Dangers of Actos and the FDA Warnings
Actos (pioglitazone) is a prescription drug used in the treatment of Type 2 Diabetes. Approved in 1999, the drug has been on the market for over thirteen years, and at one time was considered a safe alternative to the drug Avandia (which was targeted for contributing to adverse cardiovascular events in users).

January 02, 2013
Stryker Rejuvenate and ABGII Hip Implant Recipients Beware: The Stryker PER Letter and What it could mean for You
It appears that some recipients of the Stryker Rejuvenate or Stryker ABGII hip implant may have received a Product Experience Report or “PER” Letter from Stryker Orthopedics in response to either the patient, or the patient’s doctor, or even the patient’s treatment facility notifying Stryker of any issues with a specific implant.

January 01, 2013
The Stryker Product Experience Report Letter: What every Rejuvenate and ABGII Hip Implant Recipients Should Know
Perhaps you are one of the many recipients of a Stryker Rejuvenate or ABGII hip implant who have experienced problems with the implant and are unsure what to do. The Stryker Rejuvenate and Stryker ABGII were both recalled this past July, 2012.